Docplanner, a leading health-care digital platform, plans to leverage artificial intelligence to capitalize on its vast medical data. The move aims to enhance diagnostics and position the company for a future public listing, potentially unlocking new value for investors.

The startup operates one of the world's largest online doctor-booking services. Integrating AI could transform its data into actionable insights, a critical step as digital health firms race to innovate. This strategy reflects a broader industry push to monetize patient data responsibly.

An IPO would test investor appetite for health-tech amid regulatory scrutiny. Success depends on demonstrating scalable, secure AI applications that improve outcomes. Market watchers will track Docplanner's progress as a bellwether for the sector's public market debut.